A clinical study on the management of anxiety neurosis with Sankhaholi

Abstract

Sankhaholi (Evolvulus alsinoides Linn.) has been used to improve brain power, memory and to treat various psychiatric disorders. A single blind, placebo controlled study was conducted to evaluate the efficacy of Sankhaholi in 60 patients of Anxiety neurosis, belonging to 18-50 yrs of age group of both sexes. The severity of anxiety symptoms was assessed by Hamilton’s Anxiety Rating Scale (HARS), which was administered at baseline, at every week for 4 weeks, and then at 6th week of treatment (the treatment end point). In Drug group, the mean HARS score before treatment was 22.26, which was trimmed down to 12.21 after 6 weeks treatment. Whereas, in placebo group, pre-treatment mean HARS score was 23.78 and post treatment HARS score were 24.07. Sankhaholi markedly relieved anxiety symptoms without producing any side effects. Statistically the results of Sankhaholi were determined highly significant as compared to the results of placebo.